Staff Reporter
Published:
Photo from Shutterstock
The group will pay cash over seven years via internal funds and bank loans.
HC Surgical Specialists Limited has acquired the remaining 65% stake in Total Orthopaedics Pte Ltd (TOPL) for $21.41m.
HC Surgical entered into the sale and purchase agreement with TOPL surgeons Dr Benjamin Seah Renyi, Dr Huang Yilun, and Dr Hamid Rahmatullah Bin Abd Razak, and completed the acquisition on 20 October, it said in a press release.
The Catalist-listed group will pay the sum in cash over seven years, funded through internal resources and bank borrowings.
Based on audited accounts, TOPL posted a profit before tax of about $2.56m and a profit after tax of about $2.22m for the 12 months ended 31 May 2026.
HC Surgical first invested in TOPL in 2023. Dr Seah joined the group on 1 June that year, followed by Dr Huang and Dr Hamid Razak on 2 April 2024, according to CEO Dr Heah Sieu Min.
TOPL has since expanded to four orthopaedic centres at Novena Medical Centre, Shaw House, Tampines, and Gleneagles Hospital, the group added.
Incorporated in 2015, HC Surgical mainly provides endoscopic procedures, including gastroscopies and colonoscopies, as well as general surgery services with a focus on colorectal procedures.
It currently operates a network of 20 clinics across Singapore.
Join Singapore Business Review community
Follow the link for more news on
Also Read
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW
Reaching the people who run Asia's businesses is harder than it used to be.
Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.
We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.
If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.